The Asia-Pacific Animal Health market is expected grow significantly in the coming years. Increasing livestock population, growing awareness about animal health, rising demand for animal-derived food products, and rising frequency of animal disease outbreaks are some the major factors driving the growth of the Asia-Pacific Animal Health market. 

The APAC Animal Health market is estimated to grow at a CAGR of 5.7% during the forecast period to reach USD 20.25 Billion by 2021. 

+ Market Dynamics 

+ Drivers

+ Rising Demand for Animal-Derived Food Products
+ Increasing Livestock Population and Growing Awareness About Animal Health
+ Growing Frequency of Animal Disease Outbreaks

Download PDF Brochure @
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=106215485

“Growth promoters accounted for the largest share of the market in 2015”

The market is segmented into growth promoters, feed additives, vaccines, parasiticides, antimicrobials and antibiotics, and other pharmaceuticals. Growth promoters accounted for the largest share of the market in 2015 owing to its wide utilization by livestock producers and pet owners.

“The Asia pacific animal Health market is segmented into food-producing animals and companion animals.”

The market is segmented into food-producing animals and companion animals. The food-producing animals segment accounted for the largest share of the market, while companion animals are expected to register the highest growth during the forecast period.

View complete press release:-
https://www.marketsandmarkets.com/PressReleases/asia-pacific-animal-health.asp

Factors such as rapidly increasing livestock population, increasing demand for animal-derived food products, growing awareness about animal health, and rising frequency of animal disease outbreaks. 

Market Size 
The global APAC Animal Health market size is projected to reach USD 20.25 Billion by 2021 from USD 15.32 Billion in 2016, at a CAGR of 5.7%. 

Zoetis, Inc. (U.S.), Sanofi (France), Merck and Co., Inc. (U.S.), Eli Lilly and Company (U.S.), China Animal Husbandry Industry Co., Ltd. (China), Jinyu Bio-technology Co., Ltd. (China), Qingdao Yebio Bioengineering Co., Ltd. (China), Tianjin Rringpu bio-technology Co., Ltd. (China), Kyoto Biken Laboratories, Inc. (Japan), Bio-Med Private Limited (India), and Indian Immunologicals Ltd. (India), are some key players in this market. These companies are focusing on increasing their presence in the high-growth markets through both organic as well as inorganic growth strategies such as product launches, acquisitions, and expansions. 

For More Details, Download a PDF Brochure:- 
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=106215485 

“Merck and Co., Inc. (U.S.) is another significant player in the APAC animal health market” 
The company has its presence in more than 140 countries with 25 manufacturing sites located in the U.S., Mexico, Brazil, the U.K., France, Germany, Spain, the Netherlands, Germany, Italy, Austria, India, Australia, and New Zealand. The company invested USD 6,704 million, USD 7,180 Million, and USD 7,503 Million on research and development activities in 2015, 2014, and 2013, respectively, to launch new, innovative, and therapeutically effective products. 

“Sanofi (France) is involved in the research, development, manufacturing, and marketing of healthcare products for humans and animals” 
The company offers a wide range of animal health products through Merial, the animal health division of the company. In 2015, the company signed a business exchange agreement with Boehringer Ingelheim (Germany), one of the leading players in animal health products. Under this agreement, Sanofi will exchange its animal health business (Merial) with the consumer healthcare (CHC) business of Boehringer Ingelheim. 

We can help with your specific research requirement for this market. Please share your specific interest to help us serve you better, Request Sample Pages:- 
https://www.marketsandmarkets.com/requestsampleNew.asp?id=106215485

Growth in this market can majorly be attributed to factors such as rapidly increasing livestock population, increasing demand for animal-derived food products, growing awareness about animal health, and rising frequency of animal disease outbreaks. However, the shift towards vegetarian diets, rising cost of vaccine storage, and restrictions on the use of parasiticides in food-producing animals are expected to restrain the growth of the APAC animal health market. Growth in companion animal ownership and rising adoption of pet health insurance in APAC offer significant growth opportunities for players operating in the APAC animal health market.

Market Size

The global APAC Animal Health Market is expected to grow at a CAGR of 5.7% during the forecast period to reach USD 20.25 Billion by 2021.

To know about the assumptions considered for the study download the pdf brochure:- https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=106215485

“Growth promoters accounted for the largest share of the market in 2015”

Based on product, the market is segmented into growth promoters, feed additives, vaccines, parasiticides, antimicrobials and antibiotics, and other pharmaceuticals. Growth promoters accounted for the largest share of the market in 2015 owing to its wide utilization by livestock producers and pet owners.

“The Asia pacific animal Health market is segmented into food-producing animals and companion animals.”

Based on the type of animal, the market is segmented into food-producing animals and companion animals. The food-producing animals segment accounted for the largest share of the market, while companion animals are expected to register the highest growth during the forecast period.

Recent Developments

• In November 2015, the company acquired PHARMAQ (Norway), one of the leading manufacturers of vaccines for aquaculture.
• In 2015, the Sanofi (France) signed a business exchange agreement with Boehringer Ingelheim (Germany), one of the leading players in animal health products. Under this agreement, Sanofi will exchange its animal health business (Merial) with the consumer healthcare (CHC) business of Boehringer Ingelheim.

For More Details, Request Sample Pages:- https://www.marketsandmarkets.com/requestsampleNew.asp?id=106215485

According to the new market research “APAC Animal Health Market Asia-Pacific Animal Health Market by Product (Parasiticides (Endoparasiticides, Ectoparasiticides), Antimicrobial & Antibiotic, Vaccines, Feed Additive (Vitamin, Amino Acids, Antioxidant), Growth Promoter), Animal (Livestock, Companion) - Forecast to 2021", analyzes and studies the major market drivers, restraints/challenges, and opportunities. The Asia-Pacific Animal Health market is estimated to grow at a CAGR of 5.7% during the forecast period to reach USD 20.25 Billion by 2021.

The global APAC Animal Health market is segmented based on product, type of animal, and country.

Based on product, the market is segmented into growth promoters, feed additives, vaccines, parasiticides, antimicrobials and antibiotics, and other pharmaceuticals. Growth promoters accounted for the largest share of the market in 2015 owing to its wide utilization by livestock producers and pet owners.

Download a PDF Brochure:- https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=106215485

Browse and in-depth TOC on in “APAC Animal Health Market " 
116 - Tables
35 - Figures 
199 - Pages 

Based on the type of animal, the market is segmented into food-producing animals and companion animals. The food-producing animals segment accounted for the largest share of the market, while companion animals are expected to register the highest growth during the forecast period.

Request Free Sample Report @
https://www.marketsandmarkets.com/requestsampleNew.asp?id=106215485

Geographically, the Asia-Pacific Animal Health market is segmented into China, Japan, India, and the Rest of APAC. In 2015, China commanded a major share of the market and is expected to witness the highest growth rate during the forecast period. Growth in the Chinese animal health market can be attributed to the growing livestock population, increasing consumption of animal-derived food products, growing awareness about animal health and zoonotic diseases, and rising frequency of animal disease outbreaks in China.

Market Players

The key players in the APAC Animal Health market are Zoetis, Inc. (U.S.), Sanofi (France), Merck and Co., Inc. (U.S.), Eli Lilly and Company (U.S.), and Boehringer Ingelheim GmbH (Germany), Bayer AG (Germany), Ceva Santé Animale (France), Virbac (France), Perrigo Company Plc. (U.S.), Vetoquinol S.A. (France), Cargill, Inc. (U.S.), Royal DSM N.V. (Netherlands), and Evonik Industries AG (Germany).

View Complete Press Release @ 
https://www.marketsandmarkets.com/PressReleases/asia-pacific-animal-health.asp

The global APAC Animal Health market report analyzes and studies the major market drivers, restraints, challenges, and opportunities in China, Japan, India, and the Rest of Asia-Pacific.

Factors such as the rapid rise in livestock population, increasing awareness about animal health, growing demand for animal-derived food products, and rising frequency of animal disease outbreaks are the major factors driving the growth of the Asia-Pacific Animal Health market.

Download PDF Brochure@ 
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=106215485

Based on product, the market is segmented into growth promoters, feed additives, parasiticides, vaccines, antimicrobials and antibiotics, and other pharmaceuticals. The growth promoters segment accounted for the largest share of the market owing to its wide utilization by livestock producers and pet owners.

Based on type of animal, the market is segmented into food-producing animals and companion animals. The food-producing animals segment held the largest share of the Asia-Pacific Animal Health market, while the companion animals segment is expected to witness the highest growth during the forecast period.

Read More@ 
https://www.marketsandmarkets.com/PressReleases/asia-pacific-animal-health.asp

China is the largest regional segment for the APAC animal health market and is expected to witness the highest growth rate during the forecast period. The large share of this regional segment is driven by the increasing livestock population, rising demand for animal-derived food products in China, increasing pet ownership, and growing adoption of pet insurance. Key players operating in this market include Zoetis, Inc. (U.S.), Sanofi (France), Merck and Co., Inc. (U.S.), Eli Lilly and Company (U.S.), and Boehringer Ingelheim GmbH (Germany).

Other players include Bayer AG (Germany), Ceva Santé Animale (France), Virbac (France), Perrigo Company Plc. (U.S.), Vetoquinol S.A. (France), Cargill, Inc. (U.S.), Royal DSM N.V. (Netherlands), and Evonik Industries AG (Germany).